These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 1358781)

  • 1. p53 Mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients.
    Escher A; Piotet E; Waridel F; Iggo R; Monnier P
    Eur Arch Otorhinolaryngol; 2009 Apr; 266(4):547-51. PubMed ID: 18688630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.
    Casson AG; Tammemagi M; Eskandarian S; Redston M; McLaughlin J; Ozcelik H
    Mol Pathol; 1998 Apr; 51(2):71-9. PubMed ID: 9713589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative activity and p53 protein accumulation correlate with early invasive trend, and apoptosis correlates with differentiation grade in oesophageal squamous cell carcinomas.
    Ohashi K; Nemoto T; Eishi Y; Matsuno A; Nakamura K; Hirokawa K
    Virchows Arch; 1997 Feb; 430(2):107-15. PubMed ID: 9083513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of p53 and c-erbB-2 proteins is associated with histological type, tumour stage, and cell proliferation in malignant salivary gland tumours.
    Kamio N
    Virchows Arch; 1996 May; 428(2):75-83. PubMed ID: 8925128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of DNA topoisomerase II in human gastric disorders.
    Yabuki N; Sasano H; Kato K; Ohara S; Toyota T; Nagura H; Miyaike M; Nozaki N; Kikuchi A
    Am J Pathol; 1996 Sep; 149(3):997-1007. PubMed ID: 8780403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma.
    Seregard S
    J Clin Pathol; 1996 Apr; 49(4):338-42. PubMed ID: 8655713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody for detecting p53 protein by immunohistochemistry in normal tissues.
    Pezzella F; Micklem K; Turley H; Pulford K; Jones M; Kocialkowski S; Delia D; Aiello A; Bicknell R; Smith K
    J Clin Pathol; 1994 Jul; 47(7):592-6. PubMed ID: 8089212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus.
    Duhaylongsod FG; Gottfried MR; Iglehart JD; Vaughn AL; Wolfe WG
    Ann Surg; 1995 Jun; 221(6):677-83; discussion 683-4. PubMed ID: 7794072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p53 and flow cytometric DNA analysis of isolated neoplastic glands of the stomach: an application of the gland isolation method.
    Kitayama Y; Sugimura H; Tanaka M; Nakamura S; Kino I
    Virchows Arch; 1995; 426(6):557-62. PubMed ID: 7655735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53 protein related to human papillomavirus and DNA ploidy in superficial esophageal carcinoma.
    Nakamura T; Ide H; Eguchi R; Hayashi K; Hanyu F; Nagasako K; Yukawa M; Asaka K; Fujimori T; Maeda S
    Surg Today; 1995; 25(7):591-7. PubMed ID: 7549269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis.
    Wang LD; Shi ST; Zhou Q; Goldstein S; Hong JY; Shao P; Qiu SL; Yang CS
    Int J Cancer; 1994 Nov; 59(4):514-9. PubMed ID: 7960222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus.
    Sarbia M; Porschen R; Borchard F; Horstmann O; Willers R; Gabbert HE
    Cancer; 1994 Oct; 74(8):2218-23. PubMed ID: 7922972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
    Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
    Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression.
    Sasano H; Miyazaki S; Gooukon Y; Nishihira T; Sawai T; Nagura H
    Hum Pathol; 1992 Nov; 23(11):1238-43. PubMed ID: 1358781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
    Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
    Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 immunolocalization in cytology specimens: a study in human esophageal carcinoma.
    Goukon Y; Sasano H; Nishihira T; Mori S; Nagura H
    Diagn Cytopathol; 1994; 11(2):113-8. PubMed ID: 7813357
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.